nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C9—Disulfiram—alcohol dependence	0.15	0.351	CbGbCtD
Sitaxentan—CYP2C19—Citalopram—alcohol dependence	0.128	0.3	CbGbCtD
Sitaxentan—CYP3A4—Disulfiram—alcohol dependence	0.087	0.204	CbGbCtD
Sitaxentan—CYP3A4—Citalopram—alcohol dependence	0.062	0.145	CbGbCtD
Sitaxentan—EDNRB—adrenal cortex—alcohol dependence	0.00246	0.102	CbGeAlD
Sitaxentan—EDNRB—pancreas—alcohol dependence	0.00218	0.0909	CbGeAlD
Sitaxentan—EDNRA—adrenal cortex—alcohol dependence	0.00203	0.0847	CbGeAlD
Sitaxentan—EDNRB—midbrain—alcohol dependence	0.00175	0.073	CbGeAlD
Sitaxentan—EDNRB—testis—alcohol dependence	0.00147	0.0612	CbGeAlD
Sitaxentan—EDNRA—midbrain—alcohol dependence	0.00145	0.0604	CbGeAlD
Sitaxentan—EDNRB—liver—alcohol dependence	0.00139	0.0578	CbGeAlD
Sitaxentan—EDNRB—cerebellum—alcohol dependence	0.00136	0.0565	CbGeAlD
Sitaxentan—EDNRA—testis—alcohol dependence	0.00121	0.0506	CbGeAlD
Sitaxentan—EDNRB—brain—alcohol dependence	0.0011	0.0459	CbGeAlD
Sitaxentan—EDNRA—brain—alcohol dependence	0.00091	0.0379	CbGeAlD
Sitaxentan—CYP2C19—digestive system—alcohol dependence	0.000657	0.0274	CbGeAlD
Sitaxentan—CYP2C19—blood—alcohol dependence	0.000626	0.0261	CbGeAlD
Sitaxentan—CYP2C9—cardiovascular system—alcohol dependence	0.000614	0.0256	CbGeAlD
Sitaxentan—CYP2C19—endocrine gland—alcohol dependence	0.000543	0.0226	CbGeAlD
Sitaxentan—CYP2C9—digestive system—alcohol dependence	0.000509	0.0212	CbGeAlD
Sitaxentan—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000491	0.00127	CcSEcCtD
Sitaxentan—CYP2C19—liver—alcohol dependence	0.00049	0.0204	CbGeAlD
Sitaxentan—Bronchitis—Acamprosate—alcohol dependence	0.000489	0.00127	CcSEcCtD
Sitaxentan—Ventricular tachycardia—Citalopram—alcohol dependence	0.000486	0.00126	CcSEcCtD
Sitaxentan—Hiccups—Citalopram—alcohol dependence	0.000486	0.00126	CcSEcCtD
Sitaxentan—Pulmonary embolism—Citalopram—alcohol dependence	0.000486	0.00126	CcSEcCtD
Sitaxentan—Blood pressure increased—Citalopram—alcohol dependence	0.000486	0.00126	CcSEcCtD
Sitaxentan—CYP2C9—blood—alcohol dependence	0.000485	0.0202	CbGeAlD
Sitaxentan—Dermatitis contact—Citalopram—alcohol dependence	0.00048	0.00125	CcSEcCtD
Sitaxentan—Eructation—Citalopram—alcohol dependence	0.000477	0.00124	CcSEcCtD
Sitaxentan—Wheezing—Citalopram—alcohol dependence	0.000472	0.00122	CcSEcCtD
Sitaxentan—Pollakiuria—Acamprosate—alcohol dependence	0.00047	0.00122	CcSEcCtD
Sitaxentan—Angina pectoris—Naltrexone—alcohol dependence	0.000469	0.00122	CcSEcCtD
Sitaxentan—Colitis—Citalopram—alcohol dependence	0.000466	0.00121	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Acamprosate—alcohol dependence	0.000464	0.0012	CcSEcCtD
Sitaxentan—Candida infection—Citalopram—alcohol dependence	0.000464	0.0012	CcSEcCtD
Sitaxentan—Bronchitis—Naltrexone—alcohol dependence	0.000463	0.0012	CcSEcCtD
Sitaxentan—Fluid retention—Citalopram—alcohol dependence	0.000461	0.0012	CcSEcCtD
Sitaxentan—Abdominal discomfort—Naltrexone—alcohol dependence	0.000461	0.0012	CcSEcCtD
Sitaxentan—Weight decreased—Acamprosate—alcohol dependence	0.00046	0.00119	CcSEcCtD
Sitaxentan—Vaginal infection—Citalopram—alcohol dependence	0.000459	0.00119	CcSEcCtD
Sitaxentan—Hyperglycaemia—Acamprosate—alcohol dependence	0.000459	0.00119	CcSEcCtD
Sitaxentan—Photophobia—Citalopram—alcohol dependence	0.000456	0.00118	CcSEcCtD
Sitaxentan—Dry eye—Citalopram—alcohol dependence	0.000449	0.00116	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000447	0.00116	CcSEcCtD
Sitaxentan—Myocardial infarction—Acamprosate—alcohol dependence	0.000444	0.00115	CcSEcCtD
Sitaxentan—Stomatitis—Acamprosate—alcohol dependence	0.000442	0.00115	CcSEcCtD
Sitaxentan—Neoplasm—Citalopram—alcohol dependence	0.000439	0.00114	CcSEcCtD
Sitaxentan—Weight decreased—Naltrexone—alcohol dependence	0.000435	0.00113	CcSEcCtD
Sitaxentan—Haematuria—Acamprosate—alcohol dependence	0.000432	0.00112	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.00043	0.00262	CbGpPWpGaD
Sitaxentan—Infestation NOS—Naltrexone—alcohol dependence	0.000429	0.00111	CcSEcCtD
Sitaxentan—Infestation—Naltrexone—alcohol dependence	0.000429	0.00111	CcSEcCtD
Sitaxentan—Epistaxis—Acamprosate—alcohol dependence	0.000428	0.00111	CcSEcCtD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000425	0.00259	CbGpPWpGaD
Sitaxentan—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000423	0.0011	CcSEcCtD
Sitaxentan—Mental disability—Citalopram—alcohol dependence	0.000422	0.00109	CcSEcCtD
Sitaxentan—Asthenia—Disulfiram—alcohol dependence	0.000421	0.00109	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—CNR1—alcohol dependence	0.000421	0.00257	CbGpPWpGaD
Sitaxentan—CYP2C9—endocrine gland—alcohol dependence	0.000421	0.0175	CbGeAlD
Sitaxentan—Myocardial infarction—Naltrexone—alcohol dependence	0.00042	0.00109	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—OPRD1—alcohol dependence	0.000417	0.00254	CbGpPWpGaD
Sitaxentan—Conjunctivitis—Naltrexone—alcohol dependence	0.000417	0.00108	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000414	0.00253	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000414	0.00252	CbGpPWpGaD
Sitaxentan—Ear pain—Citalopram—alcohol dependence	0.000413	0.00107	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—DRD2—alcohol dependence	0.000411	0.0025	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR7—alcohol dependence	0.000411	0.0025	CbGpPWpGaD
Sitaxentan—Haemoglobin—Acamprosate—alcohol dependence	0.000409	0.00106	CcSEcCtD
Sitaxentan—EDNRA—G alpha (q) signalling events—HTR2A—alcohol dependence	0.000408	0.00249	CbGpPWpGaD
Sitaxentan—Rhinitis—Acamprosate—alcohol dependence	0.000408	0.00106	CcSEcCtD
Sitaxentan—Sleep disorder—Citalopram—alcohol dependence	0.000407	0.00106	CcSEcCtD
Sitaxentan—Hepatitis—Acamprosate—alcohol dependence	0.000407	0.00106	CcSEcCtD
Sitaxentan—Haemorrhage—Acamprosate—alcohol dependence	0.000407	0.00106	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—OPRM1—alcohol dependence	0.000407	0.00248	CbGpPWpGaD
Sitaxentan—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000406	0.00105	CcSEcCtD
Sitaxentan—Epistaxis—Naltrexone—alcohol dependence	0.000405	0.00105	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—OPRK1—alcohol dependence	0.000404	0.00246	CbGpPWpGaD
Sitaxentan—Sinusitis—Naltrexone—alcohol dependence	0.000402	0.00104	CcSEcCtD
Sitaxentan—Oedema peripheral—Acamprosate—alcohol dependence	0.000401	0.00104	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—PDYN—alcohol dependence	0.0004	0.00244	CbGpPWpGaD
Sitaxentan—Gastroenteritis—Citalopram—alcohol dependence	0.000398	0.00103	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000396	0.00241	CbGpPWpGaD
Sitaxentan—Deafness—Citalopram—alcohol dependence	0.000394	0.00102	CcSEcCtD
Sitaxentan—Hepatic failure—Citalopram—alcohol dependence	0.000392	0.00102	CcSEcCtD
Sitaxentan—Visual impairment—Acamprosate—alcohol dependence	0.000392	0.00102	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000392	0.00239	CbGpPWpGaD
Sitaxentan—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.00039	0.00238	CbGpPWpGaD
Sitaxentan—CYP3A4—digestive system—alcohol dependence	0.000388	0.0162	CbGeAlD
Sitaxentan—Dizziness—Disulfiram—alcohol dependence	0.000388	0.00101	CcSEcCtD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000388	0.00236	CbGpPWpGaD
Sitaxentan—Nasal congestion—Citalopram—alcohol dependence	0.000387	0.001	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000386	0.00235	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000386	0.00235	CbGpPWpGaD
Sitaxentan—Hepatitis—Naltrexone—alcohol dependence	0.000385	0.000999	CcSEcCtD
Sitaxentan—CYP2C9—liver—alcohol dependence	0.00038	0.0158	CbGeAlD
Sitaxentan—Tinnitus—Acamprosate—alcohol dependence	0.000379	0.000985	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—OPRD1—alcohol dependence	0.000379	0.00231	CbGpPWpGaD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000379	0.00231	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000378	0.0023	CbGpPWpGaD
Sitaxentan—Increased appetite—Citalopram—alcohol dependence	0.000375	0.000974	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—NPY—alcohol dependence	0.000374	0.00228	CbGpPWpGaD
Sitaxentan—Menopausal symptoms—Citalopram—alcohol dependence	0.000374	0.00097	CcSEcCtD
Sitaxentan—Visual disturbance—Citalopram—alcohol dependence	0.000372	0.000966	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CRHR1—alcohol dependence	0.000372	0.00227	CbGpPWpGaD
Sitaxentan—CYP3A4—blood—alcohol dependence	0.00037	0.0154	CbGeAlD
Sitaxentan—Rash—Disulfiram—alcohol dependence	0.00037	0.000961	CcSEcCtD
Sitaxentan—Headache—Disulfiram—alcohol dependence	0.000368	0.000954	CcSEcCtD
Sitaxentan—Immune system disorder—Acamprosate—alcohol dependence	0.000368	0.000954	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.000366	0.00223	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000365	0.00223	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PDYN—alcohol dependence	0.000363	0.00222	CbGpPWpGaD
Sitaxentan—Arthritis—Citalopram—alcohol dependence	0.000363	0.000942	CcSEcCtD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000362	0.00221	CbGpPWpGaD
Sitaxentan—Cardiac failure—Citalopram—alcohol dependence	0.000361	0.000938	CcSEcCtD
Sitaxentan—Hypoglycaemia—Citalopram—alcohol dependence	0.000361	0.000938	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CRH—alcohol dependence	0.000361	0.0022	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR1B—alcohol dependence	0.000361	0.0022	CbGpPWpGaD
Sitaxentan—Eye disorder—Naltrexone—alcohol dependence	0.00036	0.000934	CcSEcCtD
Sitaxentan—Alopecia—Acamprosate—alcohol dependence	0.00036	0.000933	CcSEcCtD
Sitaxentan—Tinnitus—Naltrexone—alcohol dependence	0.000359	0.000932	CcSEcCtD
Sitaxentan—Cardiac disorder—Naltrexone—alcohol dependence	0.000357	0.000927	CcSEcCtD
Sitaxentan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000357	0.00217	CbGpPWpGaD
Sitaxentan—Mental disorder—Acamprosate—alcohol dependence	0.000356	0.000925	CcSEcCtD
Sitaxentan—Malnutrition—Acamprosate—alcohol dependence	0.000354	0.000919	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000353	0.000915	CcSEcCtD
Sitaxentan—Osteoarthritis—Citalopram—alcohol dependence	0.000353	0.000915	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000352	0.00215	CbGpPWpGaD
Sitaxentan—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000352	0.00215	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CHRM2—alcohol dependence	0.00035	0.00213	CbGpPWpGaD
Sitaxentan—Angiopathy—Naltrexone—alcohol dependence	0.000349	0.000907	CcSEcCtD
Sitaxentan—Immune system disorder—Naltrexone—alcohol dependence	0.000348	0.000903	CcSEcCtD
Sitaxentan—Tension—Acamprosate—alcohol dependence	0.000348	0.000902	CcSEcCtD
Sitaxentan—Migraine—Citalopram—alcohol dependence	0.000347	0.000901	CcSEcCtD
Sitaxentan—Mediastinal disorder—Naltrexone—alcohol dependence	0.000347	0.000901	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—AVP—alcohol dependence	0.000346	0.00211	CbGpPWpGaD
Sitaxentan—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000345	0.00211	CbGpPWpGaD
Sitaxentan—Nervousness—Acamprosate—alcohol dependence	0.000344	0.000893	CcSEcCtD
Sitaxentan—Muscle spasms—Acamprosate—alcohol dependence	0.000341	0.000884	CcSEcCtD
Sitaxentan—Alopecia—Naltrexone—alcohol dependence	0.00034	0.000883	CcSEcCtD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000338	0.00206	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CRHR1—alcohol dependence	0.000338	0.00206	CbGpPWpGaD
Sitaxentan—Mental disorder—Naltrexone—alcohol dependence	0.000337	0.000876	CcSEcCtD
Sitaxentan—Malnutrition—Naltrexone—alcohol dependence	0.000335	0.00087	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000333	0.00203	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—OPRK1—alcohol dependence	0.000333	0.00203	CbGpPWpGaD
Sitaxentan—Tremor—Acamprosate—alcohol dependence	0.000332	0.000861	CcSEcCtD
Sitaxentan—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000332	0.00202	CbGpPWpGaD
Sitaxentan—Ataxia—Citalopram—alcohol dependence	0.000332	0.000861	CcSEcCtD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00033	0.00201	CbGpPWpGaD
Sitaxentan—Tension—Naltrexone—alcohol dependence	0.000329	0.000854	CcSEcCtD
Sitaxentan—Ill-defined disorder—Acamprosate—alcohol dependence	0.000329	0.000853	CcSEcCtD
Sitaxentan—Dehydration—Citalopram—alcohol dependence	0.000328	0.000851	CcSEcCtD
Sitaxentan—Anaemia—Acamprosate—alcohol dependence	0.000327	0.00085	CcSEcCtD
Sitaxentan—Liver function test abnormal—Citalopram—alcohol dependence	0.000326	0.000845	CcSEcCtD
Sitaxentan—Agitation—Acamprosate—alcohol dependence	0.000326	0.000845	CcSEcCtD
Sitaxentan—Nervousness—Naltrexone—alcohol dependence	0.000326	0.000845	CcSEcCtD
Sitaxentan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000325	0.00198	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000325	0.00198	CbGpPWpGaD
Sitaxentan—Dry skin—Citalopram—alcohol dependence	0.000323	0.000839	CcSEcCtD
Sitaxentan—Muscle spasms—Naltrexone—alcohol dependence	0.000322	0.000836	CcSEcCtD
Sitaxentan—Abdominal pain upper—Citalopram—alcohol dependence	0.000322	0.000836	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Citalopram—alcohol dependence	0.000322	0.000836	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000322	0.00196	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—OPRM1—alcohol dependence	0.000321	0.00196	CbGpPWpGaD
Sitaxentan—CYP3A4—endocrine gland—alcohol dependence	0.000321	0.0134	CbGeAlD
Sitaxentan—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000321	0.00196	CbGpPWpGaD
Sitaxentan—Malaise—Acamprosate—alcohol dependence	0.000319	0.000829	CcSEcCtD
Sitaxentan—Breast disorder—Citalopram—alcohol dependence	0.000319	0.000827	CcSEcCtD
Sitaxentan—Vertigo—Acamprosate—alcohol dependence	0.000318	0.000826	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CHRM2—alcohol dependence	0.000318	0.00194	CbGpPWpGaD
Sitaxentan—Cramp muscle—Citalopram—alcohol dependence	0.000318	0.000824	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000318	0.000824	CcSEcCtD
Sitaxentan—Leukopenia—Acamprosate—alcohol dependence	0.000317	0.000823	CcSEcCtD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000316	0.00192	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—DRD4—alcohol dependence	0.000316	0.00192	CbGpPWpGaD
Sitaxentan—Tremor—Naltrexone—alcohol dependence	0.000314	0.000815	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000312	0.0019	CbGpPWpGaD
Sitaxentan—Muscular weakness—Citalopram—alcohol dependence	0.000311	0.000807	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000311	0.000807	CcSEcCtD
Sitaxentan—Ill-defined disorder—Naltrexone—alcohol dependence	0.000311	0.000807	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000311	0.0019	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000309	0.00188	CbGpPWpGaD
Sitaxentan—Agitation—Naltrexone—alcohol dependence	0.000308	0.000799	CcSEcCtD
Sitaxentan—Asthma—Citalopram—alcohol dependence	0.000305	0.000791	CcSEcCtD
Sitaxentan—Malaise—Naltrexone—alcohol dependence	0.000302	0.000785	CcSEcCtD
Sitaxentan—Eosinophilia—Citalopram—alcohol dependence	0.000302	0.000783	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000302	0.00184	CbGpPWpGaD
Sitaxentan—Chest pain—Acamprosate—alcohol dependence	0.000302	0.000783	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CNR1—alcohol dependence	0.000301	0.00184	CbGpPWpGaD
Sitaxentan—CYP3A4—nervous system—alcohol dependence	0.0003	0.0125	CbGeAlD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000299	0.000777	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—OPRD1—alcohol dependence	0.000299	0.00182	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000298	0.00182	CbGpPWpGaD
Sitaxentan—Discomfort—Acamprosate—alcohol dependence	0.000298	0.000773	CcSEcCtD
Sitaxentan—Angina pectoris—Citalopram—alcohol dependence	0.000297	0.000771	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—NPY—alcohol dependence	0.000295	0.0018	CbGpPWpGaD
Sitaxentan—Dry mouth—Acamprosate—alcohol dependence	0.000295	0.000766	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—DRD2—alcohol dependence	0.000294	0.00179	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR7—alcohol dependence	0.000294	0.00179	CbGpPWpGaD
Sitaxentan—Bronchitis—Citalopram—alcohol dependence	0.000293	0.000761	CcSEcCtD
Sitaxentan—Abdominal discomfort—Citalopram—alcohol dependence	0.000292	0.000758	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—OPRM1—alcohol dependence	0.000292	0.00178	CbGpPWpGaD
Sitaxentan—Confusional state—Acamprosate—alcohol dependence	0.000291	0.000757	CcSEcCtD
Sitaxentan—CYP3A4—liver—alcohol dependence	0.000289	0.0121	CbGeAlD
Sitaxentan—Pancytopenia—Citalopram—alcohol dependence	0.000289	0.000751	CcSEcCtD
Sitaxentan—CYP3A4—central nervous system—alcohol dependence	0.000289	0.0121	CbGeAlD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000289	0.00176	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR2A—alcohol dependence	0.000288	0.00175	CbGpPWpGaD
Sitaxentan—Infection—Acamprosate—alcohol dependence	0.000287	0.000746	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—PDYN—alcohol dependence	0.000286	0.00175	CbGpPWpGaD
Sitaxentan—Chest pain—Naltrexone—alcohol dependence	0.000285	0.000741	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CRH—alcohol dependence	0.000285	0.00174	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR1B—alcohol dependence	0.000285	0.00174	CbGpPWpGaD
Sitaxentan—Dysuria—Citalopram—alcohol dependence	0.000285	0.00074	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000283	0.00173	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000283	0.000736	CcSEcCtD
Sitaxentan—Thrombocytopenia—Acamprosate—alcohol dependence	0.000283	0.000735	CcSEcCtD
Sitaxentan—Tachycardia—Acamprosate—alcohol dependence	0.000282	0.000732	CcSEcCtD
Sitaxentan—Discomfort—Naltrexone—alcohol dependence	0.000282	0.000732	CcSEcCtD
Sitaxentan—Pollakiuria—Citalopram—alcohol dependence	0.000282	0.000731	CcSEcCtD
Sitaxentan—Skin disorder—Acamprosate—alcohol dependence	0.000281	0.000729	CcSEcCtD
Sitaxentan—Dry mouth—Naltrexone—alcohol dependence	0.000279	0.000724	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Citalopram—alcohol dependence	0.000278	0.000722	CcSEcCtD
Sitaxentan—Confusional state—Naltrexone—alcohol dependence	0.000276	0.000716	CcSEcCtD
Sitaxentan—Weight decreased—Citalopram—alcohol dependence	0.000276	0.000716	CcSEcCtD
Sitaxentan—Anorexia—Acamprosate—alcohol dependence	0.000276	0.000715	CcSEcCtD
Sitaxentan—Hyperglycaemia—Citalopram—alcohol dependence	0.000275	0.000714	CcSEcCtD
Sitaxentan—Oedema—Naltrexone—alcohol dependence	0.000274	0.00071	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000273	0.00166	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000272	0.00166	CbGpPWpGaD
Sitaxentan—Infection—Naltrexone—alcohol dependence	0.000272	0.000705	CcSEcCtD
Sitaxentan—Infestation NOS—Citalopram—alcohol dependence	0.000272	0.000705	CcSEcCtD
Sitaxentan—Infestation—Citalopram—alcohol dependence	0.000272	0.000705	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—OPRD1—alcohol dependence	0.000271	0.00165	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00027	0.00165	CbGpPWpGaD
Sitaxentan—Hypotension—Acamprosate—alcohol dependence	0.00027	0.000701	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—NPY—alcohol dependence	0.000268	0.00164	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Naltrexone—alcohol dependence	0.000268	0.000696	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Citalopram—alcohol dependence	0.000268	0.000695	CcSEcCtD
Sitaxentan—Tachycardia—Naltrexone—alcohol dependence	0.000267	0.000693	CcSEcCtD
Sitaxentan—Myocardial infarction—Citalopram—alcohol dependence	0.000266	0.000691	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CRHR1—alcohol dependence	0.000266	0.00162	CbGpPWpGaD
Sitaxentan—Skin disorder—Naltrexone—alcohol dependence	0.000266	0.00069	CcSEcCtD
Sitaxentan—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000265	0.00162	CbGpPWpGaD
Sitaxentan—Stomatitis—Citalopram—alcohol dependence	0.000265	0.000688	CcSEcCtD
Sitaxentan—Jaundice—Citalopram—alcohol dependence	0.000265	0.000688	CcSEcCtD
Sitaxentan—Conjunctivitis—Citalopram—alcohol dependence	0.000264	0.000686	CcSEcCtD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000264	0.00161	CbGpPWpGaD
Sitaxentan—Insomnia—Acamprosate—alcohol dependence	0.000261	0.000679	CcSEcCtD
Sitaxentan—Anorexia—Naltrexone—alcohol dependence	0.000261	0.000677	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PDYN—alcohol dependence	0.00026	0.00159	CbGpPWpGaD
Sitaxentan—Haematuria—Citalopram—alcohol dependence	0.000259	0.000673	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—HTR1B—alcohol dependence	0.000259	0.00158	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CRH—alcohol dependence	0.000259	0.00158	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000259	0.00158	CbGpPWpGaD
Sitaxentan—Somnolence—Acamprosate—alcohol dependence	0.000257	0.000667	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Citalopram—alcohol dependence	0.000257	0.000667	CcSEcCtD
Sitaxentan—Epistaxis—Citalopram—alcohol dependence	0.000256	0.000665	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000256	0.00156	CbGpPWpGaD
Sitaxentan—Sinusitis—Citalopram—alcohol dependence	0.000255	0.000662	CcSEcCtD
Sitaxentan—Dyspepsia—Acamprosate—alcohol dependence	0.000254	0.000661	CcSEcCtD
Sitaxentan—Decreased appetite—Acamprosate—alcohol dependence	0.000251	0.000652	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CHRM2—alcohol dependence	0.00025	0.00153	CbGpPWpGaD
Sitaxentan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00025	0.000648	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD4—alcohol dependence	0.000249	0.00152	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000249	0.00152	CbGpPWpGaD
Sitaxentan—Bradycardia—Citalopram—alcohol dependence	0.000248	0.000645	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—AVP—alcohol dependence	0.000247	0.00151	CbGpPWpGaD
Sitaxentan—Insomnia—Naltrexone—alcohol dependence	0.000247	0.000642	CcSEcCtD
Sitaxentan—Pain—Acamprosate—alcohol dependence	0.000247	0.000642	CcSEcCtD
Sitaxentan—Constipation—Acamprosate—alcohol dependence	0.000247	0.000642	CcSEcCtD
Sitaxentan—Haemoglobin—Citalopram—alcohol dependence	0.000245	0.000636	CcSEcCtD
Sitaxentan—Rhinitis—Citalopram—alcohol dependence	0.000245	0.000635	CcSEcCtD
Sitaxentan—Haemorrhage—Citalopram—alcohol dependence	0.000244	0.000633	CcSEcCtD
Sitaxentan—Hepatitis—Citalopram—alcohol dependence	0.000244	0.000633	CcSEcCtD
Sitaxentan—Somnolence—Naltrexone—alcohol dependence	0.000243	0.000631	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CRHR1—alcohol dependence	0.000242	0.00147	CbGpPWpGaD
Sitaxentan—Urinary tract disorder—Citalopram—alcohol dependence	0.000241	0.000625	CcSEcCtD
Sitaxentan—Oedema peripheral—Citalopram—alcohol dependence	0.00024	0.000624	CcSEcCtD
Sitaxentan—Urethral disorder—Citalopram—alcohol dependence	0.000239	0.000621	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—OPRK1—alcohol dependence	0.000238	0.00145	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Acamprosate—alcohol dependence	0.000238	0.000618	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CNR1—alcohol dependence	0.000238	0.00145	CbGpPWpGaD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000238	0.00145	CbGpPWpGaD
Sitaxentan—Decreased appetite—Naltrexone—alcohol dependence	0.000238	0.000617	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000236	0.000613	CcSEcCtD
Sitaxentan—Fatigue—Naltrexone—alcohol dependence	0.000236	0.000612	CcSEcCtD
Sitaxentan—Visual impairment—Citalopram—alcohol dependence	0.000235	0.00061	CcSEcCtD
Sitaxentan—Pain—Naltrexone—alcohol dependence	0.000234	0.000607	CcSEcCtD
Sitaxentan—Constipation—Naltrexone—alcohol dependence	0.000234	0.000607	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD2—alcohol dependence	0.000232	0.00142	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR7—alcohol dependence	0.000232	0.00142	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—OPRM1—alcohol dependence	0.00023	0.0014	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—POMC—alcohol dependence	0.00023	0.0014	CbGpPWpGaD
Sitaxentan—Urticaria—Acamprosate—alcohol dependence	0.00023	0.000596	CcSEcCtD
Sitaxentan—Body temperature increased—Acamprosate—alcohol dependence	0.000229	0.000593	CcSEcCtD
Sitaxentan—Eye disorder—Citalopram—alcohol dependence	0.000228	0.000592	CcSEcCtD
Sitaxentan—Tinnitus—Citalopram—alcohol dependence	0.000227	0.00059	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CHRM2—alcohol dependence	0.000227	0.00139	CbGpPWpGaD
Sitaxentan—Flushing—Citalopram—alcohol dependence	0.000226	0.000588	CcSEcCtD
Sitaxentan—Cardiac disorder—Citalopram—alcohol dependence	0.000226	0.000588	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—DRD4—alcohol dependence	0.000226	0.00138	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.000226	0.00138	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Naltrexone—alcohol dependence	0.000225	0.000585	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—OPRD1—alcohol dependence	0.000224	0.00137	CbGpPWpGaD
Sitaxentan—Angiopathy—Citalopram—alcohol dependence	0.000221	0.000574	CcSEcCtD
Sitaxentan—Immune system disorder—Citalopram—alcohol dependence	0.00022	0.000572	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.00022	0.00134	CbGpPWpGaD
Sitaxentan—Mediastinal disorder—Citalopram—alcohol dependence	0.00022	0.000571	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000217	0.00133	CbGpPWpGaD
Sitaxentan—Urticaria—Naltrexone—alcohol dependence	0.000217	0.000564	CcSEcCtD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000217	0.00132	CbGpPWpGaD
Sitaxentan—Body temperature increased—Naltrexone—alcohol dependence	0.000216	0.000561	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CNR1—alcohol dependence	0.000216	0.00132	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000216	0.00132	CbGpPWpGaD
Sitaxentan—Alopecia—Citalopram—alcohol dependence	0.000216	0.00056	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PDYN—alcohol dependence	0.000215	0.00131	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000214	0.00131	CbGpPWpGaD
Sitaxentan—Mental disorder—Citalopram—alcohol dependence	0.000214	0.000555	CcSEcCtD
Sitaxentan—Hypersensitivity—Acamprosate—alcohol dependence	0.000213	0.000553	CcSEcCtD
Sitaxentan—Malnutrition—Citalopram—alcohol dependence	0.000212	0.000551	CcSEcCtD
Sitaxentan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000212	0.00129	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—NPY—alcohol dependence	0.000211	0.00129	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD2—alcohol dependence	0.000211	0.00129	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR7—alcohol dependence	0.000211	0.00129	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—OPRM1—alcohol dependence	0.000209	0.00127	CbGpPWpGaD
Sitaxentan—Tension—Citalopram—alcohol dependence	0.000208	0.000541	CcSEcCtD
Sitaxentan—Asthenia—Acamprosate—alcohol dependence	0.000207	0.000538	CcSEcCtD
Sitaxentan—Nervousness—Citalopram—alcohol dependence	0.000206	0.000535	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000206	0.00126	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2A—alcohol dependence	0.000206	0.00126	CbGpPWpGaD
Sitaxentan—Muscle spasms—Citalopram—alcohol dependence	0.000204	0.00053	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CRH—alcohol dependence	0.000204	0.00124	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR1B—alcohol dependence	0.000204	0.00124	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Naltrexone—alcohol dependence	0.000202	0.000523	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—WASF2—alcohol dependence	0.0002	0.00122	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CRHR1—alcohol dependence	0.0002	0.00122	CbGpPWpGaD
Sitaxentan—Tremor—Citalopram—alcohol dependence	0.000199	0.000516	CcSEcCtD
Sitaxentan—Diarrhoea—Acamprosate—alcohol dependence	0.000198	0.000513	CcSEcCtD
Sitaxentan—Ill-defined disorder—Citalopram—alcohol dependence	0.000197	0.000511	CcSEcCtD
Sitaxentan—Anaemia—Citalopram—alcohol dependence	0.000196	0.000509	CcSEcCtD
Sitaxentan—Asthenia—Naltrexone—alcohol dependence	0.000196	0.000509	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—AVP—alcohol dependence	0.000195	0.00119	CbGpPWpGaD
Sitaxentan—Agitation—Citalopram—alcohol dependence	0.000195	0.000507	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.000192	0.00117	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—NPY—alcohol dependence	0.000192	0.00117	CbGpPWpGaD
Sitaxentan—Malaise—Citalopram—alcohol dependence	0.000191	0.000497	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—WASF1—alcohol dependence	0.000191	0.00117	CbGpPWpGaD
Sitaxentan—Dizziness—Acamprosate—alcohol dependence	0.000191	0.000496	CcSEcCtD
Sitaxentan—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000191	0.00116	CbGpPWpGaD
Sitaxentan—Vertigo—Citalopram—alcohol dependence	0.000191	0.000495	CcSEcCtD
Sitaxentan—Leukopenia—Citalopram—alcohol dependence	0.00019	0.000493	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CHRM2—alcohol dependence	0.000188	0.00114	CbGpPWpGaD
Sitaxentan—Diarrhoea—Naltrexone—alcohol dependence	0.000187	0.000486	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000187	0.00114	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR1B—alcohol dependence	0.000185	0.00113	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CRH—alcohol dependence	0.000185	0.00113	CbGpPWpGaD
Sitaxentan—Vomiting—Acamprosate—alcohol dependence	0.000184	0.000477	CcSEcCtD
Sitaxentan—Rash—Acamprosate—alcohol dependence	0.000182	0.000473	CcSEcCtD
Sitaxentan—Dermatitis—Acamprosate—alcohol dependence	0.000182	0.000473	CcSEcCtD
Sitaxentan—Headache—Acamprosate—alcohol dependence	0.000181	0.00047	CcSEcCtD
Sitaxentan—Dizziness—Naltrexone—alcohol dependence	0.000181	0.00047	CcSEcCtD
Sitaxentan—Chest pain—Citalopram—alcohol dependence	0.000181	0.000469	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00018	0.000466	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000179	0.00109	CbGpPWpGaD
Sitaxentan—Discomfort—Citalopram—alcohol dependence	0.000179	0.000464	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD4—alcohol dependence	0.000178	0.00109	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AVP—alcohol dependence	0.000177	0.00108	CbGpPWpGaD
Sitaxentan—Dry mouth—Citalopram—alcohol dependence	0.000177	0.000459	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000175	0.00107	CbGpPWpGaD
Sitaxentan—Confusional state—Citalopram—alcohol dependence	0.000175	0.000454	CcSEcCtD
Sitaxentan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000174	0.00106	CbGpPWpGaD
Sitaxentan—Vomiting—Naltrexone—alcohol dependence	0.000174	0.000451	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000174	0.00106	CbGpPWpGaD
Sitaxentan—Oedema—Citalopram—alcohol dependence	0.000173	0.00045	CcSEcCtD
Sitaxentan—Rash—Naltrexone—alcohol dependence	0.000172	0.000448	CcSEcCtD
Sitaxentan—Dermatitis—Naltrexone—alcohol dependence	0.000172	0.000447	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—OPRM1—alcohol dependence	0.000172	0.00105	CbGpPWpGaD
Sitaxentan—Infection—Citalopram—alcohol dependence	0.000172	0.000447	CcSEcCtD
Sitaxentan—Nausea—Acamprosate—alcohol dependence	0.000172	0.000446	CcSEcCtD
Sitaxentan—Headache—Naltrexone—alcohol dependence	0.000171	0.000445	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CNR1—alcohol dependence	0.00017	0.00104	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Citalopram—alcohol dependence	0.00017	0.000441	CcSEcCtD
Sitaxentan—Thrombocytopenia—Citalopram—alcohol dependence	0.00017	0.00044	CcSEcCtD
Sitaxentan—Tachycardia—Citalopram—alcohol dependence	0.000169	0.000439	CcSEcCtD
Sitaxentan—Skin disorder—Citalopram—alcohol dependence	0.000168	0.000437	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD2—alcohol dependence	0.000166	0.00101	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR7—alcohol dependence	0.000166	0.00101	CbGpPWpGaD
Sitaxentan—Anorexia—Citalopram—alcohol dependence	0.000165	0.000429	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—POMC—alcohol dependence	0.000164	0.001	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000164	0.001	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2A—alcohol dependence	0.000163	0.000991	CbGpPWpGaD
Sitaxentan—Nausea—Naltrexone—alcohol dependence	0.000162	0.000422	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—DRD4—alcohol dependence	0.000162	0.000988	CbGpPWpGaD
Sitaxentan—Hypotension—Citalopram—alcohol dependence	0.000162	0.00042	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—OPRD1—alcohol dependence	0.00016	0.000977	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NPY—alcohol dependence	0.000159	0.000967	CbGpPWpGaD
Sitaxentan—Insomnia—Citalopram—alcohol dependence	0.000157	0.000407	CcSEcCtD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000155	0.000944	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CNR1—alcohol dependence	0.000155	0.000943	CbGpPWpGaD
Sitaxentan—Somnolence—Citalopram—alcohol dependence	0.000154	0.0004	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PDYN—alcohol dependence	0.000154	0.000937	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000154	0.000936	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR1B—alcohol dependence	0.000153	0.000933	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CRH—alcohol dependence	0.000153	0.000933	CbGpPWpGaD
Sitaxentan—Dyspepsia—Citalopram—alcohol dependence	0.000153	0.000396	CcSEcCtD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000151	0.000924	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD2—alcohol dependence	0.000151	0.00092	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR7—alcohol dependence	0.000151	0.00092	CbGpPWpGaD
Sitaxentan—Decreased appetite—Citalopram—alcohol dependence	0.000151	0.000391	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00015	0.000388	CcSEcCtD
Sitaxentan—Fatigue—Citalopram—alcohol dependence	0.000149	0.000388	CcSEcCtD
Sitaxentan—Constipation—Citalopram—alcohol dependence	0.000148	0.000385	CcSEcCtD
Sitaxentan—Pain—Citalopram—alcohol dependence	0.000148	0.000385	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2A—alcohol dependence	0.000148	0.0009	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000143	0.000872	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Citalopram—alcohol dependence	0.000143	0.000371	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CRHR1—alcohol dependence	0.000143	0.000871	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—WASF2—alcohol dependence	0.000143	0.000871	CbGpPWpGaD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000141	0.000861	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000141	0.00086	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.00014	0.000854	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AVP—alcohol dependence	0.00014	0.000853	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000138	0.000842	CbGpPWpGaD
Sitaxentan—Urticaria—Citalopram—alcohol dependence	0.000138	0.000357	CcSEcCtD
Sitaxentan—Body temperature increased—Citalopram—alcohol dependence	0.000137	0.000356	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—WASF1—alcohol dependence	0.000137	0.000835	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000136	0.000828	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CHRM2—alcohol dependence	0.000134	0.000819	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD4—alcohol dependence	0.000134	0.000815	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—POMC—alcohol dependence	0.00013	0.000792	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000129	0.000784	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Citalopram—alcohol dependence	0.000128	0.000331	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CNR1—alcohol dependence	0.000128	0.000778	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AVP—alcohol dependence	0.000127	0.000774	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.000126	0.00077	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD2—alcohol dependence	0.000125	0.000759	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR7—alcohol dependence	0.000125	0.000759	CbGpPWpGaD
Sitaxentan—Asthenia—Citalopram—alcohol dependence	0.000124	0.000323	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—OPRM1—alcohol dependence	0.000123	0.000752	CbGpPWpGaD
Sitaxentan—Diarrhoea—Citalopram—alcohol dependence	0.000119	0.000308	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—POMC—alcohol dependence	0.000118	0.000719	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2A—alcohol dependence	0.000116	0.00071	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000116	0.000704	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000115	0.000703	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000115	0.0007	CbGpPWpGaD
Sitaxentan—Dizziness—Citalopram—alcohol dependence	0.000115	0.000297	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—NPY—alcohol dependence	0.000113	0.000692	CbGpPWpGaD
Sitaxentan—Vomiting—Citalopram—alcohol dependence	0.00011	0.000286	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CRH—alcohol dependence	0.000109	0.000667	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR1B—alcohol dependence	0.000109	0.000667	CbGpPWpGaD
Sitaxentan—Rash—Citalopram—alcohol dependence	0.000109	0.000284	CcSEcCtD
Sitaxentan—Dermatitis—Citalopram—alcohol dependence	0.000109	0.000283	CcSEcCtD
Sitaxentan—Headache—Citalopram—alcohol dependence	0.000109	0.000282	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2A—alcohol dependence	0.000106	0.000644	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AVP—alcohol dependence	0.000105	0.000639	CbGpPWpGaD
Sitaxentan—Nausea—Citalopram—alcohol dependence	0.000103	0.000267	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—DRD4—alcohol dependence	9.57e-05	0.000583	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	9.31e-05	0.000568	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—POMC—alcohol dependence	9.29e-05	0.000567	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	9.23e-05	0.000563	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CNR1—alcohol dependence	9.13e-05	0.000557	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	9.11e-05	0.000555	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD2—alcohol dependence	8.91e-05	0.000543	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR7—alcohol dependence	8.91e-05	0.000543	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADH6—alcohol dependence	8.88e-05	0.000541	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—alcohol dependence	8.72e-05	0.000532	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GGT1—alcohol dependence	8.48e-05	0.000517	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—POMC—alcohol dependence	8.44e-05	0.000515	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—POMC—alcohol dependence	8.23e-05	0.000502	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADH6—alcohol dependence	8.09e-05	0.000494	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—MAOA—alcohol dependence	7.6e-05	0.000463	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AVP—alcohol dependence	7.5e-05	0.000457	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—POMC—alcohol dependence	7.5e-05	0.000457	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADH1A—alcohol dependence	7.35e-05	0.000449	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—POMC—alcohol dependence	6.97e-05	0.000425	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADH1A—alcohol dependence	6.71e-05	0.000409	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADH4—alcohol dependence	6.25e-05	0.000381	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—alcohol dependence	6.24e-05	0.000381	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADH4—alcohol dependence	5.7e-05	0.000348	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.41e-05	0.00033	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADH6—alcohol dependence	5.34e-05	0.000325	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADH7—alcohol dependence	5.32e-05	0.000324	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GGT2—alcohol dependence	5.1e-05	0.000311	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—POMC—alcohol dependence	4.99e-05	0.000304	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.95e-05	0.000302	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.94e-05	0.000301	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADH7—alcohol dependence	4.85e-05	0.000296	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADH1B—alcohol dependence	4.66e-05	0.000284	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GGT2—alcohol dependence	4.65e-05	0.000283	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EP300—alcohol dependence	4.62e-05	0.000282	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.42e-05	0.00027	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADH1B—alcohol dependence	4.25e-05	0.000259	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MAOB—alcohol dependence	3.86e-05	0.000236	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADH4—alcohol dependence	3.76e-05	0.000229	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MAOB—alcohol dependence	3.52e-05	0.000215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EP300—alcohol dependence	3.31e-05	0.000202	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDH2—alcohol dependence	3.28e-05	0.0002	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADH7—alcohol dependence	3.2e-05	0.000195	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.16e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GGT2—alcohol dependence	3.07e-05	0.000187	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDH2—alcohol dependence	3e-05	0.000183	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.88e-05	0.000176	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.8e-05	0.000171	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GOT2—alcohol dependence	2.79e-05	0.00017	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2E1—alcohol dependence	2.63e-05	0.00016	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GOT2—alcohol dependence	2.55e-05	0.000155	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GGT1—alcohol dependence	2.41e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GOT1—alcohol dependence	2.41e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2E1—alcohol dependence	2.39e-05	0.000146	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MAOB—alcohol dependence	2.32e-05	0.000142	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GOT1—alcohol dependence	2.2e-05	0.000134	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GGT1—alcohol dependence	2.2e-05	0.000134	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MAOA—alcohol dependence	2.16e-05	0.000132	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.1e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.98e-05	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MAOA—alcohol dependence	1.97e-05	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.91e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GOT2—alcohol dependence	1.68e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.58e-05	9.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GOT1—alcohol dependence	1.45e-05	8.84e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GGT1—alcohol dependence	1.45e-05	8.84e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—alcohol dependence	1.41e-05	8.58e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MAOA—alcohol dependence	1.3e-05	7.92e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—alcohol dependence	1.28e-05	7.82e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—EP300—alcohol dependence	9.33e-06	5.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—EP300—alcohol dependence	8.51e-06	5.19e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—alcohol dependence	8.46e-06	5.16e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—EP300—alcohol dependence	5.61e-06	3.42e-05	CbGpPWpGaD
